Larvol Delta - Arch-Biopartners-Expands-the-Primary-Endpoint-of-its-Phase-II-Trial-to-Include-Prevention-of-Multiple-Organ-Injuries-in-Patients-with-COVID19

MetaBlok (lsalt peptide) - Arch Biopartners

http://www.globenewswire.com/news-release/2020/05/19/2035994/0/en/Arch-Biopartners-Expands-the-Primary-Endpoint-of-its-Phase-II-Trial-to-Include-Prevention-of-Multiple-Organ-Injuries-in-Patients-with-COVID-19.html

May 19, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next